Compare Charles River Laboratories Intl. Inc (CRL) vs ThredUp Inc (TDUP) Price & Performance

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

TDUP trades at $6.18, down 6.36% over 24 hours, with a mixed technical picture showing bullish moving averages but bearish oscillators. The company reported Q1 2026 revenue of $81.7 million, a 15% year-over-year increase, though net losses persist. Recent news highlights the launch of a peer-to-peer marketplace and AI-driven shopping features, signaling innovation efforts. Analyst sentiment remains positive with a consensus price target of $6.90 and 57% buy ratings.

The outlook hinges on TDUP's ability to leverage AI for cost reduction and growth in its resale platform, but risks include sustained profitability challenges and competitive pressures. With cash flow improving and debt levels manageable, the stock offers speculative upside if execution aligns with bullish analyst expectations.